The Big Interview: Mirabaud AM's CEO on why the Geneva-founded firm is a UK asset manager at heart

A 'strong' UK culture

Valeria Martinez
clock • 6 min read

The last time Lionel Aeschlimann sat down for a Big Interview with Investment Week was nearly a decade ago. Only two years into the launch of Mirabaud Asset Management, he said the business was “a start-up with deep roots”.

Founded in 1819, the Geneva-based private bank Mirabaud Group boasts of a long and successful history. However, when Aeschlimann joined the group as managing partner in the aftermath of the Global Financial Crisis, he saw an opportunity to bring its asset management capabilities out of the shadows.  Since then, Mirabaud AM has grown its assets under management to CHF 9.5bn (£8.5bn) of client money in traditional and alternative investments, and has more than 100 staff. Ten years on, its chief executive Aeschlimann says the firm "has grown some teeth".  "We are the youngest child in th...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Companies

Monzo fined £21m by FCA for failings in financial crime controls

Monzo fined £21m by FCA for failings in financial crime controls

Around 34,000 high-risk clients onboarded

Linus Uhlig
clock 08 July 2025 • 2 min read
Citi becomes minority investor in HANetf

Citi becomes minority investor in HANetf

Growing interest in European ETFs

Patrick Brusnahan
clock 03 July 2025 • 2 min read
AstraZeneca CEO mulls moving listing to the US – reports

AstraZeneca CEO mulls moving listing to the US – reports

Latest blow to LSE

Linus Uhlig
clock 02 July 2025 • 1 min read
Trustpilot